Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

NCT: NCT05591118 · ACTIVE_NOT_RECRUITING

NCT IDNCT05591118
StatusACTIVE_NOT_RECRUITING
Start Date2023-07-17
Completion2027-08-04
SponsorNYU Langone Health (OTHER)
First posted
Last updated

Brief Summary

PE-TRACT is an open-label, assessor-blinded, randomized trial, aiming to compare catheter-directed therapy (CDT) and anticoagulation (CDT group) with anticoagulation alone (No-CDT) in 500 patients with submassive PE, proximal pulmonary artery thrombus and right ventricular dilation.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑